Frontlight ResearchEarly access
Trial site
Oncology Hematology Care Clinical Trials, LLC
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Pfizer3 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- AbbVie1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Genprex, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026